Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-08-02), Suzuken Co's 14-Day RSI is 47.58.
The industry rank for Suzuken Co's 14-Day RSI or its related term are showing as below:
TSE:9987's 14-Day RSI is ranked better than 64.8% of 125
companies
in the Medical Distribution industry
Industry Median: 50.55
vs TSE:9987: 47.58
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Suzuken Co 14-Day RSI Related Terms
TSE:9987 vs MCK, COR, CAH: 14-Day RSI Comparison
For the Medical Distribution subindustry, Suzuken Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzuken Co 14-Day RSI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Suzuken Co's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Suzuken Co's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzuken Co (TSE:9987) has a 14-Day RSI of 47.58 as of Aug. 02, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Suzuken Co and its competitors. According to the industry distribution chart, Suzuken Co ranks #44 out of 125 companies in the Medical Distribution industry, placing it in the top 35.2%.
Is Suzuken Co's 14-Day RSI too high?
Suzuken Co's current 14-Day RSI is 47.58. The Medical Distribution industry median 14-Day RSI is 50.55. Suzuken Co's value of 47.58 is 5.9% below this industry median. Based on the distribution chart, Suzuken Co ranks #44 out of 125 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Suzuken Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Suzuken Co's 14-Day RSI compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Suzuken Co ranks #44 out of 125 companies for 14-Day RSI. This puts Suzuken Co in the upper half of its industry. The industry median 14-Day RSI is 50.55. Suzuken Co's value of 47.58 is 5.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Distribution company?
The median 14-Day RSI among Medical Distribution companies is 50.55, based on 125 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Suzuken Co's current 14-Day RSI of 47.58 is 5.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Suzuken Co and its competitors. For the Medical Distribution industry, the median 14-Day RSI is 50.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzuken Co's current 14-Day RSI is 47.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzuken Co stock overvalued right now?
Based on GuruFocus' analysis, Suzuken Co (TSE:9987) is currently considered Modestly Undervalued. The stock's GF Value™ is 円5,925.70, compared to a current price of 円5,091.00 — trading 14.1% below its estimated fair value. The current 14-Day RSI is 47.58 and 5.9% below the Medical Distribution industry median of 50.55. Suzuken Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Suzuken Co (TSE:9987), the current 14-Day RSI is 47.58 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Suzuken Co (TSE:9987) Overvalued in 2026?
Based on GuruFocus' analysis, Suzuken Co stock appears to be undervalued.
The current stock price of 円5,091.00 is trading 14.1% below its estimated GF Value™ of 円5,925.70.
GuruFocus considers Suzuken Co to be Modestly Undervalued.
Key valuation signals for TSE:9987:
14-Day RSI: 47.58
GF Value™: 円5,925.70 vs. price of 円5,091.00 (14.1% below fair value)
Industry Position: 5.9% below the Medical Distribution median (#44 of 125)
No single metric tells the full story. See the TSE:9987 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Suzuken Co Ltd is engaged in the manufacture and sale of pharmaceuticals and medical devices, and in providing insurance, pharmacy, and nursing care services. The company operates through segments, including Pharmaceutical Wholesale business, Healthcare product development business, Specialty Pharmaceuticals Distribution business, Regional medical nursing care support business, and Medical-related Services business. It generates the majority of its revenue from the Pharmaceutical Wholesale Business segment, which sells prescription pharmaceuticals, diagnostic reagents, medical equipment, and medical supplies.
79GF Score
Get the complete analysis for TSE:9987
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9987 has been successfully added to your 
